id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-3877-0003,FDA,FDA-2019-P-3877,"Determination That GLUCOPHAGE (Metformin Hydrochloride) Oral Tablets, 500 Milligrams, 850 Milligrams, and 1 Gram, and GLUCOPHAGE XR (Metformin Hydrochloride) Oral Extended-Release Tablets, 500 Milligrams and 750 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T14:31:28Z,2019-28270,0,0,090000648425d320
FDA-2019-P-3877-0004,FDA,FDA-2019-P-3877,Response Letter to Harman Finochem Limited Updated from FDA CDER,Other,Agency Response,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T19:24:26Z,,0,0,090000648425fa9c
FDA-2019-P-3877-0002,FDA,FDA-2019-P-3877,Acknowledgment Letter from FDA DMS to Harman Finochem Limited,Other,Acknowledgement Letter/Receipt,2019-08-20T04:00:00Z,2019,8,2019-08-20T04:00:00Z,,2019-08-20T15:56:54Z,,0,0,0900006483e6b6a3
FDA-2019-P-3877-0001,FDA,FDA-2019-P-3877,Citizen Petition from Harman Finochem Limited,Other,Citizen Petition,2019-08-20T04:00:00Z,2019,8,2019-08-20T04:00:00Z,,2024-11-12T23:07:07Z,,1,0,0900006483e5c0a8